Clinical Trial Update: Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Gliadel wafers in combination with temozolomide (Temodar) for primary glioblastoma multiforme has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Gliadel wafers (carmustine wafer)
• Temodar (Temozolomide)

Snippet

Sponsor: University of Iowa | Conditions: Primary Glioblastoma Multiforme | Phase 2 | Status: TERMINATED